Active Ingredient(s): Inotersen Sodium
FDA Approved: * October 5, 2018
Pharm Company: * AKCEA THERAPS
Category: Neurological Disorders

Polyneuropathy (poly- + neuro- + -pathy) is damage or disease affecting peripheral nerves (peripheral neuropathy) in roughly the same areas on both sides of the body, featuring weakness, numbness, and burning pain.[1] It usually begins in the hands and feet and may progress to the arms and legs and sometimes to other parts of the body where it may affect the autonomic nervous system. It may be acute or chronic. A number of different disorders may cause polyneuropathy, includin... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Tegsedi 284 mg/1.5ml Subcutaneous Injection, Solution
NDC: 72126-007
Akcea Therapeutics, Inc.